Patents by Inventor Gregory Lee Durst

Gregory Lee Durst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted benzopyrans as selective estrogen receptor-beta agonists
    Patent number: 7842822
    Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: November 30, 2010
    Assignee: Eli Lilly and Company
    Inventors: Gregory Lee Durst, Bryan Hurst Norman, Timothy Ivo Richardson
  • SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS
    Publication number: 20090298925
    Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.
    Type: Application
    Filed: July 31, 2009
    Publication date: December 3, 2009
    Inventors: Gregory Lee Durst, Bryan Hurst Norman, Lance Allen Pfeifer, Timothy Ivo Richardson
  • SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS
    Publication number: 20080312312
    Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.
    Type: Application
    Filed: August 1, 2008
    Publication date: December 18, 2008
    Inventors: Gregory Lee Durst, Bryan Hurst Norman, Lance Allen Pfeifer, Timothy Ivo Richardson
  • Substituted benzopyrans as selective estrogen receptor-beta agonists
    Patent number: 7442812
    Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor ? agonists for treating Estrogen Receptor ? mediated diseases such as benign prostatic hyperplasia.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: October 28, 2008
    Assignee: Eli Lilly and Company
    Inventors: Gregory Lee Durst, Bryan Hurst Norman, Timothy Ivo Richardson
  • Substituted benzopyrans as selective estrogen receptor-beta agonists
    Patent number: 7279499
    Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor ? agonists. Such agonists are useful for the treating Estrogen Receptor ? mediated diseases such as prostate cancer or BPH.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: October 9, 2007
    Assignee: Eli Lilly and Company
    Inventors: Gregory Lee Durst, Bryan Hurst Norman, Lance Allen Pfeifer, Timothy Ivo Richardson